◆英語タイトル:University of Florida - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013569
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, nursing, engineering, pharmacy, fine arts and veterinary medicine, among others. It also offers advertising, marketing and public relations and human services, among others. The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others. UF is headquartered in Gainesville, Florida, the US.
University of Florida – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Florida, Medical Devices Deals, 2011 to YTD 2017 9
University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Florida, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 11
Partnerships 12
Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 12
CRISPR Therapeutics to Enter into Agreement with University of Florid 13
Prosolia Enters into Research Agreement with University of Florida 14
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 15
IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 16
Licensing Agreements 17
DNAtrix Enters into Licensing Agreement with University of Florida 17
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 18
NuVax Therapeutics Enters Into Licensing Agreement With University of Florida 19
Asset Transactions 20
Oceanyx Pharma Acquires Rights to Marine Natural-Product Chemistry Library from University of Florida 20
University of Florida – Key Competitors 21
University of Florida – Key Employees 22
University of Florida – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 24
Sep 26, 2017: Study outlines precancerous treatment of anal lesions 27
Aug 29, 2017: Morehouse School of Medicine Joins the NIH All of Us Research Consortium 28
Jul 26, 2017: Waterlogged brain region helps scientists gauge damage caused by Parkinson’s disease 29
Oct 17, 2016: FDA awards 21 grants to stimulate product development for rare diseases 30
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 32
Jul 28, 2016: Bayer Recognizes Research in Hemophilia and Bleeding Disorders for Fourteenth Straight Year 34
Mar 24, 2016: Hyundai Hope On Wheels Unveils $13 Million Commitment To Childhood Cancer In 2016, Marks More Than $115 Million Of Funding To Date 35
Mar 24, 2016: Hyundai Hope On Wheels Announces Recipients Of $1 Million Quantum Grant To Fund Transformational Pediatric Cancer Research 36
Feb 12, 2016: Researchers present inner workings of Ebola vaccine trial 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
University of Florida, Pharmaceuticals & Healthcare, Key Facts 2
University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Florida, Deals By Therapy Area, 2011 to YTD 2017 8
University of Florida, Medical Devices Deals, 2011 to YTD 2017 9
University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Colorescience Raises US$10 Million In Series A Financing 11
Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 12
CRISPR Therapeutics to Enter into Agreement with University of Florid 13
Prosolia Enters into Research Agreement with University of Florida 14
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 15
IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 16
DNAtrix Enters into Licensing Agreement with University of Florida 17
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 18
NuVax Therapeutics Enters Into Licensing Agreement With University of Florida 19
Oceanyx Pharma Acquires Rights to Marine Natural-Product Chemistry Library from University of Florida 20
University of Florida, Key Competitors 21
University of Florida, Key Employees 22
University of Florida, Subsidiaries 23